Burning extra calories with a 'futile protein cycle'

Christopher Lynch of The Pennsylvania State University College of Medicine and his colleagues found that they could drive such heightened protein turnover in mice by disrupting an enzyme involved in the metabolism of some amino acids, the building blocks of proteins. The enzyme-deficient animals showed elevated blood levels of the essential amino acid leucine, an important nutrient signal, and became slimmer than normal mice despite eating more food. They also showed “remarkable” improvements in glucose and insulin tolerance, and resistance to becoming obese on a high-fat diet.

“The mice on the outside look normal, just skinnier and smaller,” Lynch said. “After looking at their metabolism, we found that for the same activity, they were using more energy.”

Moreover, the researchers found that the animals that ate the most food also expended the most energy. “That would be ideal for people who are overweight,” Lynch said. “They could continue to eat and just waste the energy and be thin.”

Abundant food supplies and a sedentary lifestyle have contributed to the current epidemic of obesity in Western nations, the researchers said. Obesity results when people consume more energy in their diet than they expend. In both short-term and relatively long-term studies, high-protein and low-fat diets have been found to increase energy expenditure, they noted, while short-term protein intake helps stave off hunger.

The effects of dietary protein are thought to be driven at least in part by leucine and perhaps other so-called branched-chain amino acids (BCAAs). Yet it has remained unclear whether leucine supplementation actually improves or worsens obesity, Lynch said.

In the current study, the researchers generated mice lacking the enzyme BCATm, critical for the first step in BCAA breakdown, which caused their leucine levels to rise by more than 10-fold. As a result of the enzyme deficiency, the animals ate more food but were lean in comparison to normal mice. The researchers traced the effect to an energy-demanding increase in protein turnover that appeared to be directly related to the amount of food the mice ate.

“Unfortunately for dieters, it appears unlikely that the tactic used by the [mutant mice] to avoid weight gain, i.e., a big increase in protein turnover, can be achieved by merely ingesting high-protein diets or leucine supplements,” said Susan Fried and Malcolm Watford in an accompanying commentary. An earlier study found that eating leucine can only increase its levels to twice the normal concentration, they noted. And unlike the enzyme disruption, dietary leucine stimulates protein synthesis while it slows protein breakdown.

Nonetheless, the scientists all agree that the findings could lead to new weight-loss therapies. “It is possible that revving up protein turnover by manipulating BCATm activity through pharmacological means is worth exploring as a treatment for obesity in humans,” Fried and Watford said.

Source: Cell Press

Protein shown to play a key role in normal development of nervous system
A protein that enables nerve cells to communicate with each other plays a key role in controlling the developing nervous system. Research into how that protein helps precise connections to form among nerve cells may provide a basis for eventual treatments for patients who suffer injuries to their nervous system, including spinal cord injury.
Olive oil ingredient ups the time between meals
A fatty acid found in abundance in olive oil and other "healthy" unsaturated fats has yet another benefit: it helps keep the body satisfied to prolong the time between meals.
Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder
An experimental anti-cancer drug can prevent -- and even reverse -- potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature aging, National Institutes of Health (NIH) researchers reported today.
Proteins involved in blood vessel dysfunction in type 2 diabetes are identified
According to the American Heart Association, three-fourths of people with diabetes die of some form of heart or blood-vessel disease. Previous studies have shown that cardiac function is compromised and cardiovascular diseases are increased in people with type 2 diabetes. Before vascular diseases develop in diabetics, blood-vessel cell dysfunction occurs. Using precise microscopes, University of Missouri researchers are dissecting coronary microvessels and testing which proteins are responsible for inflammation that causes blood-vessel dysfunction. By identifying the proteins that play important roles in blood-vessel dysfunction, they hope to develop new treatments for blood-vessel dysfunction in people with type 2 diabetes.
Food for thought -- regulating energy supply to the brain during fasting
If the current financial climate has taught us anything, it's that a system where over-borrowing goes unchecked eventually ends in disaster. It turns out this rule applies as much to our bodies as it does to economics. Instead of cash, our body deals in energy borrowed from muscle and given to the brain.
Form of Crohn's disease traced to disabled gut cells
Scientists report online this week in Nature that they have linked the health of specialized gut immune cells to a gene associated with Crohn's disease, an often debilitating and increasingly prevalent inflammatory bowel disorder.
Making metabolism more inefficient can reduce obesity
In a discovery that counters prevailing thought, a study in mice has found that inactivating a pair of key genes involved in "fat-burning" can actually increase energy expenditure and help lower diet-induced obesity. These unusual findings, appearing this week in the JBC, might lead to some new roads in weight-loss therapy.
Researchers develop novel anti-tumor vaccine
A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice, according to new research published in the October edition of the research journal Cancer Immunology, Immunotherapy. The vaccine uses the tumor's own protein to induce an immune system response, allowing for a personalized approach to treatment.

Burning extra calories with a 'futile protein cycle'

Related stories:

News discussion: